Use of Pretreatment Perfusion MRI-based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy.

已完结 10 由朱泽均发布于 2024/9/20 15:59:39

DOI:10.1148/radiol.240575
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1148/radiol.240575

其它数据库

Abstract：Background Neoadjuvant chemoimmunotherapy (NACI) has significantly increased the rate of pathologic complete response (pCR) in patients with early-stage triple-negative breast cancer (TNBC),

应助信息

6小时前

小贝

cda4686e772611efba5d34735aa3bc31.pdf 已采纳

6小时前

Book学术机器人

2024/9/20 15:59:40 未找到该文献，机器人已退出，请等待人工下载

2024/9/20 15:59:40 Book学术AI机器人收到请求，开始寻找文献

2024/9/20 15:59:40 已向机器人发送请求

6小时前

朱泽均发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Behavioral contributions to rehabilitation and childhood asthma.